GlassScriptPhysician profile
Taher Khalil
NPI 1821012113
$4,996.19
in general payments reported to CMS, 2019-2025
19 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,136 · 2020: $225 · 2021: $700 · 2022: $1,026 · 2023: $646 · 2024: $115 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705 · Travel and Lodging: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.32 |
| Travel and Lodging | $204.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,393.00 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $942.72 | 2019-2020 | |
| Medtronic, INC. | $586.02 | 2021-2024 | Corevalve Evolut R |
| Baylis Medical Company INC | $149.18 | 2019 | |
| Cvrx, INC. | $117.69 | 2019-2024 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $96.52 | 2019-2022 | |
| Abbott Laboratories | $83.46 | 2020-2024 | Aveir |
| E.R. Squibb & Sons, L.L.C. | $81.77 | 2020-2022 | |
| Stryker Corporation | $70.77 | 2025 | Flowtriever |
| Amarin Pharma, INC. | $68.45 | 2021 | |
| Abiomed | $64.62 | 2020-2024 | Impella |
| Vifor Pharma, INC. | $64.34 | 2023 | Veltassa, Korsuva |
| Janssen Pharmaceuticals, INC | $61.97 | 2022-2023 | Xarelto |
| Cardiovascular Systems INC. | $60.91 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $58.20 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opsens INC. | $35.96 | 2019 | |
| Shockwave Medical, INC | $31.17 | 2022 | |
| Livanova USA, INC. | $15.22 | 2023 | Lifesparc |
| Merck Sharp & Dohme LLC | $14.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taher Khalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.